Molecular genetics of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain: identification of two new point mutations in the G6PD gene
- PMID: 7577654
- DOI: 10.1111/j.1365-2141.1995.tb05246.x
Molecular genetics of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain: identification of two new point mutations in the G6PD gene
Abstract
In order to explore the nature of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain, we have analysed the G6PD gene in 11 unrelated Spanish G6PD-deficient males and their relatives by using the polymerase chain reaction and single-strand conformation polymorphism (PCR-SSCP) analysis combined with a direct PCR-sequencing procedure and PCR-restriction enzyme (RE) analysis. We have identified eight different missense mutations, six of which have been reported in previously described G6PD variants. In nine patients who had presented with acute favism we found the following mutations: G6PD A-376G-202A (four cases), G6PD Union1360T (two cases), G6PD Mediterranean563T (one case) and G6PD Aures143C (one case). In the remaining patient a novel A to G transition was found at nucleotide position 209 which has not been reported in any other ethnic group. This mutation results in a (70) Tyr to Cys substitution and the resulting G6PD variant was biochemically characterized and designated as G6PD Murcia. This new mutation creates a Bsp 1286I recognition site which enabled us to rapidly detect it by PCR-RE analysis. In two patients with chronic non-spherocytic haemolytic anaemia (CNSHA) we found the underlying genetic defects, as had been noted previously, to be located within a cluster of mutations in exon 10. One of them had the T to C transition at nucleotide 1153, causing a (385) Cys to Arg substitution, previously described in G6PD Tomah. The other, previously reported as having a variant called G6PD Clinic, has a G to A transition at nucleotide 1215 that produces a (405) Met to Ile substitution, thus confirming that G6PD Clinic is a new class I variant.
Similar articles
-
[Molecular analysis of glucose-6-dehydrogenase deficiency in Spain].Sangre (Barc). 1997 Oct;42(5):391-8. Sangre (Barc). 1997. PMID: 9424740 Spanish.
-
Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism.Hum Mutat. 1999;14(6):477-84. doi: 10.1002/(SICI)1098-1004(199912)14:6<477::AID-HUMU6>3.0.CO;2-X. Hum Mutat. 1999. PMID: 10571945
-
Two new mutations of the glucose-6-phosphate dehydrogenase (G6PD) gene associated with haemolytic anaemia: clinical, biochemical and molecular relationships.Br J Haematol. 1997 Sep;98(3):578-82. doi: 10.1046/j.1365-2141.1997.2563071.x. Br J Haematol. 1997. PMID: 9332310
-
Three new exon 10 glucose-6-phosphate dehydrogenase mutations.Blood Cells Mol Dis. 1995;21(1):64-72. doi: 10.1006/bcmd.1995.0010. Blood Cells Mol Dis. 1995. PMID: 7655862 Review.
-
Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants.Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):39-55. doi: 10.1053/beha.1999.0056. Baillieres Best Pract Res Clin Haematol. 2000. PMID: 10916677 Review.
Cited by
-
Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association.Mol Biol Rep. 2013 Feb;40(2):851-6. doi: 10.1007/s11033-012-2124-8. Epub 2012 Oct 14. Mol Biol Rep. 2013. PMID: 23065279
-
Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure.Front Pharmacol. 2022 Oct 20;13:1032938. doi: 10.3389/fphar.2022.1032938. eCollection 2022. Front Pharmacol. 2022. PMID: 36339627 Free PMC article.
-
Evaluation of Three Mutations in Codon 385 of Glucose-6-Phosphate Dehydrogenase via Biochemical and In Silico Analysis.Int J Mol Sci. 2024 Nov 22;25(23):12556. doi: 10.3390/ijms252312556. Int J Mol Sci. 2024. PMID: 39684266 Free PMC article.
-
Single-Nucleotide Polymorphisms in Glucose-6-Phosphate Dehydrogenase and their Relevance for the Deployment of Primaquine as a Radical Cure for Malaria.Am J Trop Med Hyg. 2023 Feb 6;108(3):470-476. doi: 10.4269/ajtmh.22-0468. Print 2023 Mar 1. Am J Trop Med Hyg. 2023. PMID: 36746659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous